Last updated: November 7, 2024
Sponsor: Parc de Salut Mar
Overall Status: Active - Recruiting
Phase
N/A
Condition
Amyotrophic Lateral Sclerosis (Als)
Myasthenia Gravis (Chronic Weakness)
Scar Tissue
Treatment
Transcranial Pulse Stimulation
Clinical Study ID
NCT06681610
NEU-TPS-ALS-01
FUSF-RAP-S-23-00096
Ages 21-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with diagnosis of sporadic ALS (definite or clinically probable) as definedby the World Federation of Neurology revised El Escorial criteria
SVC of 50% or greater of estimated measure and presence of measurable motor evokedpotential
21 to 80 years old and male or female
Exclusion
Exclusion Criteria:
- patients with fALS (based on medical history) that are unable to tolerate TMS andMRI studies or have a contraindication as described below
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Transcranial Pulse Stimulation
Phase:
Study Start date:
October 24, 2024
Estimated Completion Date:
December 31, 2026
Connect with a study center
Hospital del Mar
Barcelona, Catalonia 08003
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.